(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
(VCCEP) Tier 1 Pilot Submission for BENZENE - Tera
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6.1.2 Types of Adverse Health Effects Associated with Benzene Exposure.......... 35<br />
6.1.3 Animal Models <strong>for</strong> Benzene Toxicity ............................................................. 38<br />
6.1.4 Role of Metabolism and Site of Injury............................................................ 38<br />
6.1.5 Dose Metrics <strong>for</strong> Toxicity ............................................................................... 39<br />
6.1.6 Non-Cancer ................................................................................................... 40<br />
6.1.7 Cancer ........................................................................................................... 44<br />
6.1.8 Ongoing Studies ............................................................................................ 46<br />
6.1.9 Linear versus Non-Linear Extrapolation ........................................................ 47<br />
6.1.10 Petrochemical Industry and Refinery Epidemiology ...................................... 48<br />
6.1.11 Service Station Attendants and Vehicle Mechanic Epidemiology ................. 49<br />
6.1.12 Other Human Data ........................................................................................ 50<br />
6.2 Benzene Toxicology—Animal Hazard Assessment .................................................. 58<br />
6.2.1 Acute Toxicity ................................................................................................ 58<br />
6.2.2 Genetic Toxicity ............................................................................................. 58<br />
6.2.3 Reproductive and Developmental Toxicity .................................................... 70<br />
6.2.4 Transplacental Effects ................................................................................... 80<br />
6.2.5 Repeated-Exposure Toxicity in Experimental Animals.................................. 82<br />
6.2.6 Adult Neurotoxicity......................................................................................... 88<br />
6.2.7 Immunotoxicity............................................................................................... 90<br />
6.2.8 Metabolism .................................................................................................... 92<br />
7.0 Exposure Assessments...................................................................................................... 96<br />
7.1 Methodology/Scope of the Assessment .................................................................... 96<br />
7.2 Sources of Benzene Exposure................................................................................ 100<br />
7.2.1 Ambient Environmental Exposures ............................................................. 100<br />
7.2.2 Source-Specific Exposures ......................................................................... 127<br />
7.2.3 Occupational Exposure ............................................................................... 143<br />
7.2.4 Consumer Products..................................................................................... 147<br />
7.3 Summary of Children’s Exposures .......................................................................... 149<br />
8.0 Risk Assessment.............................................................................................................. 155<br />
8.1 Risk Assessment Approach .................................................................................... 155<br />
8.1.1 Dose Metrics................................................................................................ 156<br />
8.1.2 Mixtures ....................................................................................................... 157<br />
8.1.3 EPA Default Risk Assessment .................................................................... 158<br />
8.2 Toxicology Reference Values.................................................................................. 159<br />
8.2.1 Potential <strong>for</strong> Increased Sensitivity of Benzene-Induced Hematopoietic Toxicity<br />
and AML in Children................................................................................................ 160<br />
8.2.2 Reference Values <strong>for</strong> EPA Default Risk Assessment.................................. 163<br />
8.2.3 Points of Departure <strong>for</strong> Margin of Safety Assessment................................. 167<br />
8.3 Results .................................................................................................................... 169<br />
8.3.1 EPA Default Risk Assessment Approach .................................................... 169<br />
8.3.2 Margin of Safety Analysis ............................................................................ 170<br />
8.4 Risk Characterization Summary.............................................................................. 192<br />
9.0 <strong>VCCEP</strong> <strong>Tier</strong> 2 Data Needs Assessment .......................................................................... 195<br />
9.1 Hazard..................................................................................................................... 195<br />
9.2 Exposure ................................................................................................................. 196<br />
10.0 References....................................................................................................................... 197<br />
Benzene <strong>VCCEP</strong> <strong>Submission</strong> Page ii<br />
March 2006